This content is from: Premium Hedgies Eye IPOs Citadel and D1 Capital are among a slew of hedge funds gearing up for the latest health care initial public offerings. By Stephen Taub September 14, 2020
This content is from: Premium Hedge Funds Cashed In on These Health Care IPOs Move over, SPACs — hedge funds are increasingly reaping the benefits of successful health care company debuts. By Stephen Taub August 26, 2020
This content is from: Premium Hedge Funds Loved This Investment in 2019 Managers hope 2020 is another huge year for health care and biopharma IPOs. By Stephen Taub December 30, 2019
This content is from: Premium This is the IPO Market’s Healthy Corner At least four hedge fund firms are gearing up for biopharma IPOs planned for the next two weeks. By Stephen Taub October 03, 2019
This content is from: Premium Unicorn Comeback Helps Tiger Global, Viking, Valiant, and Others After the IPOs crashed last year, a turnaround is in the offing. By Michelle Celarier January 28, 2020
This content is from: Premium Biotech IPOs Are a Mixed Bag for Hedge Funds A recent spate of biotech company IPOs has yielded some early winners and losers. By Stephen Taub July 24, 2019
Sponsored A Case of Not Keeping One’s Word Goldman Sachs said it would avoid conflicts of interest, but investors and the courts say they did the opposite. Sponsored by Kessler Topaz Meltzer & Check September 16, 2020
Sponsored A Bitter Brew of Alleged Massive Fraud Co-lead plaintiffs appointed in class action against Luckin Coffee Sponsored by Kessler Topaz Meltzer & Check September 16, 2020
